Even after steroids scandals in Major League Baseball and more than 30 athletes were withheld from the winter Olympics in Vancouver for breaking anti-doping rules, why do athletes still engage in pharmacological cheating? The latest concern among sport officials is a new erythropoietin called Hematide, still in investigate trials. Dr. Gary Wadler, chairman of the World Anti-Doping Agency's Prohibited List and Methods Sub-Committee, talks to host Bruce Japsen about the never-ending battle against the abuse of pharmacology in order to enhance athletic ability.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
The Battle Continues Against Pharmacological Cheating in Sports
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Even after steroids scandals in Major League Baseball and more than 30 athletes were withheld from the winter Olympics in Vancouver for breaking anti-doping rules, why do athletes still engage in pharmacological cheating? The latest concern among sport officials is a new erythropoietin called Hematide, still in investigate trials. Dr. Gary Wadler, chairman of the World Anti-Doping Agency's Prohibited List and Methods Sub-Committee, talks to host Bruce Japsen about the never-ending battle against the abuse of pharmacology in order to enhance athletic ability.
Presenters
Facebook Comments